Free shipping on all orders over $ 500

Iberdomide

Cat. No. M6072

All AbMole products are for research use only, cannot be used for human consumption.

Iberdomide Structure
Synonym:

CC220; CC 220; CC-220

Size Price Availability Quantity
2mg USD 55  USD55 In stock
5mg USD 105  USD105 In stock
10mg USD 185  USD185 In stock
25mg USD 360  USD360 In stock
50mg USD 620  USD620 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

In vitro: Lenalidomide and pomalidomide, targeting cereblon, are immunomodulatory drugs that are clinically effective in the treatment of cancer, including newly diagnosed and relapsed multiple myeloma. Iberdomide contains a glutarimide ring that binds in the try-tryptophan pocket of cereblon and an isoindolinone ring that can interact with both cereblon and substrates. Treatment with Iberdomide results in the loss of Ikaros and Aiolos protein levels with EC50s of 1 nM and 0.5 nM. In vivo: Iberdomide (CC-220) is currently in phase 2 clinical trials for the treatment of systematic lupus erythematosus (SLE) and phase 1b/2a clinical trials for relapsed and refractory multiple myeloma (MM).

Chemical Information
Molecular Weight 449.5
Formula C25H27N3O5
CAS Number 1323403-33-3
Solubility (25°C) DMSO >100 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Grasso EJ, et al. Histochem Cell Biol. Urothelial endocytic vesicle recycling and lysosomal degradative pathway regulated by lipid membrane composition.

[2] Grasso EJ, et al. Cell Biochem Biophys. Differential response of the urothelial V-ATPase activity to the lipid environment.

Related E1/E2/E3 Enzyme Products
LS-102

LS-102 is a selective E3 ubiquitin ligase synoviolin (Syvn1) inhibitor. LS-102 inhibits the autoubiquitination of synoviolin with an IC50 of 35 μM.

NX-1607

NX-1607 is an oral, small molecule inhibitor of casitas B-lineage lymphoma proto-oncogene-b (Cbl-b) that has been shown to enhance antigen recall, reduce T cell exhaustion and increase cytokine production upon T cell receptor stimulation, overcoming suppressive signals from the tumor microenvironment (TME).

SENP1-IN-1

SENP1-IN-1 is a specific deSUMOylation protease 1 (SENP1) inhibitor. SENP1-IN-1 can be used for tumor radiosensitivity enhancement.

TRAF6 peptide

TRAF6 peptide is a specific TRAF6-p62 inhibitor.

LTP001

LTP001 is a SMURF1 antagonist that can be used in studies related to idiopathic pulmonary fibrosis (IPF).

  Catalog
Abmole Inhibitor Catalog




Keywords: Iberdomide, CC220; CC 220; CC-220 supplier, E1/E2/E3 Enzyme, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.